News

--Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy advanced laser-based ...
For a moment, it appeared Boston Scientific was having a rare bumpy quarter. Executives in April had estimated tariffs would ...
Boston Scientific to acquire Bolt Medical for $600 million upfront plus milestones. Bolt's IVL platform addresses coronary and peripheral artery disease.
Boston Scientific already owns a 26% stake in Bolt Medical. The deal is expected to be closed in the first half of 2025 and to be slightly dilutive to adjusted earnings per share for that year.
Boston Scientific BSX is slated to report second-quarter 2025 results on July 23, before the market opens. The renowned medical device manufacturer posted earnings per share (EPS) of 75 cents in the ...
Boston Scientific (NYSE: BSX) announced on Wednesday the acquisition of the ~74% stake in Bolt Medical that the medical devices company does not already own. BSX shares were trading +2.07% pre ...
Boston Scientific, which currently has an equity stake of approximately 26% in Bolt Medical, in 2019 had created the concept for the company’s Bolt IVL system: a laser-based platform used to ...
MARLBOROUGH, Mass., Jan. 8, 2025 /PRNewswire/ -- Boston Scientific Corporation (BSX) today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an ...
Boston Scientific initially developed the concept for the Bolt IVL system which helped establish Bolt Medical in 2019. As a strategic investor in Bolt Medical, Boston Scientific has an equity ...
MARLBOROUGH, Mass., Jan. 8, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer ...